142 related articles for article (PubMed ID: 34644732)
41. Elucidating the role of missense SNP of protein kinase C epsilon in HCV-induced hepatocellular carcinoma.
Rehman A; Shabbir M; Badshah Y; Khan K; Trembley JH; Ashraf NM; Afsar T; Almajwal A; Alruwaili NW; Alshamari A; Alanezi TN; Razak S
BMC Cancer; 2023 Feb; 23(1):147. PubMed ID: 36782184
[TBL] [Abstract][Full Text] [Related]
42. Significant association between MTHFR C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Sun H; Han B; Zhai H; Cheng X; Ma K
Tumour Biol; 2014 Jan; 35(1):189-93. PubMed ID: 24132589
[TBL] [Abstract][Full Text] [Related]
43. Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma.
Yuan JM; Lu SC; Van Den Berg D; Govindarajan S; Zhang ZQ; Mato JM; Yu MC
Hepatology; 2007 Sep; 46(3):749-58. PubMed ID: 17659576
[TBL] [Abstract][Full Text] [Related]
44. [A study on the association of MTHFR C677T polymorphism with genetic susceptibility to hepatocellular carcinoma].
Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ
Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):196-8. PubMed ID: 16556414
[TBL] [Abstract][Full Text] [Related]
45. The association between MTHFR gene polymorphisms and hepatocellular carcinoma risk: a meta-analysis.
Qin X; Peng Q; Chen Z; Deng Y; Huang S; Xu J; Li H; Li S; Zhao J
PLoS One; 2013; 8(2):e56070. PubMed ID: 23457501
[TBL] [Abstract][Full Text] [Related]
46. LINE-1 Methylation in Chronic HBV Infected Patients: Association with HCC, Gender and MTHFR C677T Polymorphism.
Qiao K; Zhang S; Huo Z; Hou W; Dai Q; Su R; Wang F
Clin Lab; 2020 May; 66(5):. PubMed ID: 32390395
[TBL] [Abstract][Full Text] [Related]
47. Genetic polymorphism of fibroblast growth factor receptor 2 and trinucleotide repeat-containing 9 influence the susceptibility to HCV-induced hepatocellular carcinoma.
Al-Khaykanee AM; Abdel-Rahman AA; Essa A; Gadallah AA; Ali BH; Al-Aqar AA; Badr EAE; Shehab-Eldeen S
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101636. PubMed ID: 33740609
[TBL] [Abstract][Full Text] [Related]
48. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients.
Arafa M; Besheer T; El-Eraky AM; Abo El-Khair SM; Elsamanoudy AZ
Br J Biomed Sci; 2019 Apr; 76(2):64-69. PubMed ID: 31025604
[TBL] [Abstract][Full Text] [Related]
49. Effect of CD133 polymorphisms on the risk of developing liver cirrhosis and hepatocellular carcinoma induced by viral hepatitis.
Hassan M; Nasr SM; Elzallat M
Virus Res; 2022 Apr; 312():198714. PubMed ID: 35181408
[TBL] [Abstract][Full Text] [Related]
50. Role of
Barooah P; Saikia S; Bharadwaj R; Sarmah P; Bhattacharyya M; Goswami B; Medhi S
Genet Test Mol Biomarkers; 2019 May; 23(5):325-331. PubMed ID: 30942619
[No Abstract] [Full Text] [Related]
51. Association of genetic polymorphism of BCL-2 (rs2279115) with susceptibility to HCV-related hepatocellular carcinoma.
Ahmed HS; Wahab EA; Elhady HA; Elgerby MM
Immunol Res; 2020 Aug; 68(4):189-197. PubMed ID: 32623689
[TBL] [Abstract][Full Text] [Related]
52. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
[TBL] [Abstract][Full Text] [Related]
53. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
[TBL] [Abstract][Full Text] [Related]
54. Genetic polymorphisms of proangiogenic factors seem to favor hepatocellular carcinoma development in alcoholic cirrhosis.
Machado MV; Janeiro A; Miltenberger-Miltenyi G; Cortez-Pinto H
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):438-43. PubMed ID: 24445728
[TBL] [Abstract][Full Text] [Related]
55. Significant association between the MTHFR A1298C polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Chang W; Meng Q; Liu JH; Wu LX; Chen Y; Chen SD
Genet Mol Res; 2015 Dec; 14(4):15972-80. PubMed ID: 26662389
[TBL] [Abstract][Full Text] [Related]
56. Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosis.
Ventura P; Venturelli G; Marcacci M; Fiorini M; Marchini S; Cuoghi C; Pietrangelo A
Thromb Res; 2016 May; 141():189-95. PubMed ID: 27065203
[TBL] [Abstract][Full Text] [Related]
57. Impact of FOXP1 rs2687201 genetic variant on the susceptibility to HCV-related hepatocellular carcinoma in Egyptians.
Motawi TMK; Sabry D; Shehata NI; William MM; Fahim AT
J Biochem Mol Toxicol; 2022 Mar; 36(3):e22965. PubMed ID: 34783112
[TBL] [Abstract][Full Text] [Related]
58. IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients.
Elsayed HM; Nabiel Y; Sheta T
Immunol Invest; 2017 Feb; 46(2):123-133. PubMed ID: 27819525
[TBL] [Abstract][Full Text] [Related]
59. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of trail receptor 1 (DR4) polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma.
Alsalawy NF; Darwish RK; Kamal MM; ElTaweel AE; Shousha HI; Elbaz TM
J Med Virol; 2018 Mar; 90(3):490-496. PubMed ID: 28975649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
